Severe late-onset multisystem cytomegalovirus infection in a premature neonate previously treated for congenital infection

BMC Pediatrics

Volumn 13, Issue 1, 2013, Pages

  El Sayed, Manal F ^a   Goldfarb, David M ^a   Fulford, Martha ^a   Pernica, Jeffrey M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Congenital infection; Cytomegalovirus; Ganciclovir

Indexed keywords

CEFAZOLIN; GANCICLOVIR; GENTAMICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VALGANCICLOVIR;

ARTICLE; CASE REPORT; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENCEPHALITIS; HEPATITIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PNEUMONIA; POLYMERASE CHAIN REACTION; PREMATURITY; PROTHROMBIN TIME; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; URINALYSIS; VIRUS LOAD;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; INFANT; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; RECURRENCE;

EID: 84883618545     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-13-142     Document Type: Article

References (10)

1. Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003, 143:16-25. 10.1016/S0022-3476(03)00192-6, 12915819.
2. Luck S, Sharland M. Postnatal cytomegalovirus: innocent bystander or hidden problem?. Arch Dis Child Fetal Neonatal Ed 2009, 94:F58-64.
3. Okulu E, Akin IM, Atasay B, et al. Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant. J Perinatol 2012, 32:72-74. 10.1038/jp.2011.58, 22202955.
4. Takahashi R, Tagawa M, Sanjo M, et al. Severe postnatal cytomegalovirus infection in a very premature infant. Neonatology 2007, 92:236-239. 10.1159/000103982, 17570943.
5. Kimberlin DW, Acosta EP, Sanchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008, 197:836-45. 10.1086/528376, 18279073.
6. Binda S, Mammoliti A, Primache V, et al. Pp65 antigenemia, plasma real-time PCR and DBS test in symptomatic and asymptomatic cytomegalovirus congenitally infected newborns. BMC Infect Dis 2010, 10:24. 10.1186/1471-2334-10-24, 2833163, 20149232.
7. Hayashi S, Kimura H, Oshiro M, et al. Transmission of cytomegalovirus via breast milk in extremely premature infants. J Perinatol 2011, 31(6):440-5. 10.1038/jp.2010.150, 21164427.
8. Gilbert G, Hayes K, Hudson I, et al. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to reduce leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989, 1:1228-31.
9. Shoji K, Ito N, Ito Y, et al. Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?. J Pediatr 2010, 157:331-333. 10.1016/j.jpeds.2010.02.020, 20400108.
10. Muller A, Eis-Hubinger AM, Brandhorst G, et al. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol 2008, 28:74-76. 10.1038/sj.jp.7211854, 18165832.